LNK754 is a farnesyltransferase inhibitor. It is used for the treatment of cancer and Alzheimer's disease.

In a mouse model of PD, APP(SL), at 6 months of age for 3 months, LNK-754 (0.9 mg/kg) significantly decreases α-synuclein plaques .

439153-64-7

C29H22ClN3O2

479.96

LNK754

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years